COMMUNIQUÉS West-GlobeNewswire

Motif Bio to Present at Investor Events in August and September
09/08/2018
NEW YORK, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM:MTFB) (NASDAQ:MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that the Company will [...]
Basilea starts clinical phase 3 study with antibiotic ceftobiprole in Staphylococcus aureus bacteremia (SAB)
09/08/2018
Basel, Switzerland, August 09, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today the start of a clinical phase 3 study with its antibiotic ceftobiprole. The registration study evaluates the safety and [...]
Spring Bank Announces Pricing of Public Offering of Common Stock
09/08/2018
HOPKINTON, Mass. and NEW YORK, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH) today announced the pricing of an underwritten public offering of 3,000,000 shares of its common stock at [...]
Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/08/2018
MENLO PARK, Calif., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]
Precision Therapeutics to Hold Business Update Conference Call on August 14, 2018
08/08/2018
MINNEAPOLIS, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery [...]
Sienna Senior Living Inc. Reports 2018 Second Quarter Financial Results and Announces 2% Dividend Increase
08/08/2018
MARKHAM, Ontario, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced its financial results for the three and six months ended June 30, 2018. The [...]
Helix BioPharma Corp. Closes Private Placement
08/08/2018
RICHMOND HILL, Ontario, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]
Protech Home Medical Announces Proven Expertise With New Independent Board Member
08/08/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Protech Home [...]
Cidara Provides Corporate Update and Reports Second Quarter 2018 Financial Results
08/08/2018
SAN DIEGO, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial results for the three [...]
Adamas Announces New Employment Inducement Grant
08/08/2018
EMERYVILLE, Calif., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted four new employees the option [...]
Otonomy Reports Second Quarter 2018 Financial Results and Provides Corporate Update
08/08/2018
Conference call and webcast today at 4:30 p.m. EDT SAN DIEGO, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for [...]
Teligent, Inc. Announces Second Quarter 2018 Results
08/08/2018
BUENA, N.J., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the second quarter ended June 30, 2018 [...]
INSYS Therapeutics Reports Second Quarter 2018 Results
08/08/2018
Focus remains on advancing pipeline across cannabinoid and spray platforms PHOENIX, Aug. 08, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and [...]
Nephros Reports Second Quarter 2018 Financial Results
08/08/2018
Quarterly Product Revenue Up 55% Year-over-Year; Total Revenue Up 59% Company Plans Uplist to National Stock Exchange Conference Call Scheduled for Today, August 8, 2018, at 4:30 PM EDT SOUTH ORANGE, N.J., Aug. 08, 2018 [...]
Scholar Rock Reports Second Quarter 2018 Financial Results and Updates on Business Progress
08/08/2018
Completed Initial Public Offering Raising $86.3 Million in Gross Proceeds Initiated Enrollment in Multiple-Ascending Dose Portion of Phase 1 Clinical Trial for SRK-015 On Track to Initiate Phase 2 Proof-of-Concept Study [...]
Chembio Diagnostics Appoints Dr. Mary Lake Polan to its Board of Directors
08/08/2018
MEDFORD, N.Y., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leader in point-of-care ("POC") diagnostic testing, today announced that Mary Lake Polan, M.D., Ph.D., M.P.H., has been [...]
Achillion Reports Second Quarter 2018 Financial Results
08/08/2018
- Global phase 2 clinical programs for ACH-4471 continue to expand in PNH and C3G - - Completed dosing phase 1 clinical study of ACH-5228 and initiated phase 1 study of ACH-5548 - - June 30, 2018 cash position $295.8 [...]
Zafgen to Present at the Wedbush PacGrow Healthcare Conference
08/08/2018
BOSTON, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients [...]
aTyr Pharma to Host Conference Call and Webcast of Second Quarter 2018 Financial Results on August 14, 2018
08/08/2018
SAN DIEGO, Aug. 08, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today [...]

Pages